Cutaneous Photoprotection: A Review of the Current Status and Evolving Strategies
- PMID: 32226337
- PMCID: PMC7087054
Cutaneous Photoprotection: A Review of the Current Status and Evolving Strategies
Abstract
Ultraviolet radiation (UVR) exposure is well established as the major environmental risk factor for the development of melanoma, cutaneous squamous cell carcinoma (cSCC), and basal cell carcinoma (BCC). Additional risk factors including genetic mutations, other environmental agents, and immune status are important in modulating the effects of UVR. Dermatologists advocate a multi-pronged approach to minimizing UVR exposure including lifestyle modifications, UVR protective clothing, and topically applied sun-protective products, i.e. sunscreen. New Federal Drug Administration (FDA) regulations on sunscreen have brought certain long-standing ingredients in sunscreen products under scrutiny. The FDA's proposed rule for over the counter (OTC) monograph states that the inorganic sunscreens, zinc oxide and titanium dioxide, were found to be "generally recognized as safe and effective," but cite insufficient evidence to grant organic sunscreens the same designation. This proposed rule by the FDA and our increasing understanding of multifactorial mechanisms of UVR damage are an impetus for innovation and advances in sun protective technology. A complete set of strategies designed to limit the risk of UV-induced skin cell malignant transformation and tumor development must address the fuller consideration of genetic, environmental, and immune factors that cooperatively drive cutaneous carcinogenesis. Recent advances in our understanding of the biochemical processes underpinning UVR associated cutaneous cellular damage, genotoxicity, and clonal expansion provide investigators with a spectrum of opportunities for technologic innovation in the prevention of skin cancer. Strategies to improve upon current topical sunscreen formulations have strived for broader UVR spectral coverage, more favorable aesthetics, increased adherence, and minimal penetration into the living epidermis. In addition to improved sunscreens, future topical therapies may target processes within the epidermis that contribute to carcinogenesis. These include reactive species quenching, delivery of DNA repair enzymes, and targeting of cytokines essential to the proliferation of mutant keratinocytes.
Keywords: Sunscreen; photobiology; skin cancer; ultraviolet radiation.
Copyright ©2020, Yale Journal of Biology and Medicine.
Figures
Similar articles
-
Sunscreens in the United States: Current Status and Future Outlook.Adv Exp Med Biol. 2020;1268:355-379. doi: 10.1007/978-3-030-46227-7_18. Adv Exp Med Biol. 2020. PMID: 32918228 Review.
-
Sun exposure behavior and protection: recommendations for travelers.J Travel Med. 2013 Mar-Apr;20(2):108-18. doi: 10.1111/j.1708-8305.2012.00667.x. Epub 2012 Dec 4. J Travel Med. 2013. PMID: 23464719 Review.
-
Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy.Environ Health Perspect. 2000 Mar;108 Suppl 1(Suppl 1):71-8. doi: 10.1289/ehp.00108s171. Environ Health Perspect. 2000. PMID: 10698724 Free PMC article. Review.
-
Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products.Am J Clin Dermatol. 2010 Dec 1;11(6):413-21. doi: 10.2165/11537050-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20806994
-
Update on photoprotection.Dermatol Ther. 2007 Sep-Oct;20(5):360-76. doi: 10.1111/j.1529-8019.2007.00150.x. Dermatol Ther. 2007. PMID: 18045361 Review.
Cited by
-
Beyond Traditional Sunscreens: A Review of Liposomal-Based Systems for Photoprotection.Pharmaceutics. 2024 May 15;16(5):661. doi: 10.3390/pharmaceutics16050661. Pharmaceutics. 2024. PMID: 38794323 Free PMC article. Review.
-
A novel multifunctional microneedle patch for synergistic photothermal- gas therapy against maxillofacial malignant melanoma and associated skin defects.J Nanobiotechnology. 2024 Apr 23;22(1):199. doi: 10.1186/s12951-024-02409-4. J Nanobiotechnology. 2024. PMID: 38654266 Free PMC article.
-
PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico.J Clin Lab Anal. 2024 Feb;38(3):e25010. doi: 10.1002/jcla.25010. Epub 2024 Jan 29. J Clin Lab Anal. 2024. PMID: 38287479 Free PMC article.
-
Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma.Nat Commun. 2023 Sep 5;14(1):5413. doi: 10.1038/s41467-023-41141-9. Nat Commun. 2023. PMID: 37669956 Free PMC article.
-
New developments in sunscreens.Photochem Photobiol Sci. 2023 Oct;22(10):2473-2482. doi: 10.1007/s43630-023-00453-x. Epub 2023 Aug 5. Photochem Photobiol Sci. 2023. PMID: 37543534 Review.
References
-
- Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. JAMA Dermatol. 2014;150(10):1063–71. - PubMed
-
- NCI Surveillance E. End Results Program (SEER) SEER Stat Fact Sheets: Melanoma of the Skin. 2015.
-
- Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol. 1993;129(10):1286–90. - PubMed
-
- Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw. 2010;8(8):888–96. - PubMed
-
- Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68(6):957–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical